NCT01236950 is a NA clinical trial of Essential oils mouthrinse in Gingivitis, sponsored by University of Lisbon.

Who is sponsoring NCT01236950?

NCT01236950 is sponsored by University of Lisbon.

What drugs are being tested in NCT01236950?

Interventions in NCT01236950: Essential oils mouthrinse, Delmopinol mouthrinse.

What condition does NCT01236950 study?

NCT01236950 studies Gingivitis, Dental Plaque Accumulation.

Is NCT01236950 still recruiting?

NCT01236950 is currently completed. Last updated 9 November 2010.

Last reviewed 2010-11-09 · How we verify

NCT01236950

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of an Essential Oil and a Delmopinol Mouthrinse Effect on Dental Plaque Accumulation Index, Gingivitis Index and on Streptococcus Mutans, Lactobacillus, Aerobic and Anaerobic Oral Bacteria Colony Counts.

Completed NA Last updated 9 November 2010

What this trial tests

NA trial testing Essential oils mouthrinse in Gingivitis in 90 participants. Completed in 1 September 2008.

Timeline

1 April 2007

Primary endpoint
1 April 2008

1 September 2008

Quick facts

Lead sponsor	University of Lisbon
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	90
Start date	1 April 2007
Primary completion	1 April 2008
Estimated completion	1 September 2008
Sites	1 location across Portugal

Drugs / interventions tested

Essential oils mouthrinse — full drug profile →
Delmopinol mouthrinse — full drug profile →

Conditions studied

Gingivitis — all drugs for Gingivitis →
Dental Plaque Accumulation — all drugs for Dental Plaque Accumulation →

Sponsor

University of Lisbon

Who can join

15 and older, any sex, with Gingivitis or Dental Plaque Accumulation. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Loe & Silness Gingival Index (1963)
Time frame: change from baseline in gingival index at two weeks
data collected at the begining of the study and two weeks after mouthrinse usage.
Quigley, Hein & Turesky Dental Plaque Index (1970)
Time frame: change from baseline in plaque index at two weeks
data collected at the begining of the study and two weeks after mouthrinse usage.

Sponsor's own description

The use of mouthrinses may be of relevance as a complement to daily dental hygiene procedures, especially for patients who do not comply with a proper mechanical removal of dental plaque. Essential oils and delmopinol mouthrinses are effective to reduce dental plaque accumulation and gingivitis. Also an effect on dental bacteria can be found. The study hypothesis states that there are no differences between the mouthrinses on the reduction of gingivitis and dental plaque accumulation as well on the bacterial counts of Streptococcus mutans, Lactobacillus, aerobic and anaerobic bacteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Essential oils mouthrinse

Trials testing the same drug.

NCT06607263 — Comparative Study of CPC+Zn Mouthwash, Dental Floss, and Essential Oils Mouthwash on Plaque and Gingivitis Reduction · Phase 3 · completed

Other recruiting trials for Gingivitis

Currently open trials in the same condition.

NCT07501455 — Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolera · NA · recruiting
NCT07499596 — Effect of Morus Nigra Mouthwash on Gingivitis Treatment · NA · recruiting
NCT07270705 — Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis · NA · recruiting
NCT07164989 — Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients · NA · active not recruiting
NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting

Other University of Lisbon trials

Trials by the same sponsor.

NCT07276191 — UL Smile: A Mobile Health Application to Promote Oral Health in Portuguese Adolescents · NA · recruiting
NCT06760663 — The Load-velocity Relationship: Neuromuscular Adaptations to Resistance Training · NA · completed
NCT05798299 — Efficacy Study of a Child-centered Version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disord · NA · unknown
NCT05436002 — Treatment of Buccal Ginvigal Recessions With the Tunnel Technique in Conjunction With Cross-linked Hyaluronic Acid and S · NA · unknown
NCT05179746 — Adjunctive Benefit of Electrolytic Cleaning on Non-surgical Treatment of Peri-implantitis. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01236950 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Lisbon
Last refreshed: 9 November 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01236950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing